Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin-12 is a **guanine-nucleotide binding protein** in the septin family of cytoskeletal GTPases, encoded by the SEPTIN12 gene on human chromosome 16[2][3][1][6]. It forms filaments and interacts with other septins (such as SEPTIN7, SEPTIN6, SEPTIN2, SEPTIN4), especially at the sperm annulus, which is crucial for sperm tail integrity and motility[1][2]. Its primary role is in the morphogenesis and elongation of sperm heads and tails during spermatogenesis, likely via association with tubulins. Variants or dysfunction of SEPTIN12 are associated with specific types of male infertility, especially those related to sperm motility and structural defects[2][3][6]. There is no evidence that SEPTIN12 is targeted by any current therapies or used as a clinical biomarker, and it is not a conventional drug target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin-12 (SEPTIN12).